Fig. 5 (abstract P705).From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)A) Tumor-specific infiltrating CD8+ T cells increase 24 days after treatment. Animals were implanted with SIYRYYGL-expressing B16 cells and 24 days after treatment the tumor was collected and analyzed. B) Anti-PD-L1 treatment reduces tumor growthBack to article page